Tech Company Financing Transactions

Surrozen Funding Round

On 3/15/2019, Surrozen raised $50 million in Series B investment from Hartford HealthCare, Horizons Ventures and NS Investment.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds from the financing will be used to advance the Company's antibody discovery and development programs in liver disease, and to expand the Company's therapeutic platform into additional disease areas where Wnt modulation has therapeutic potential.

Company Information

Company Status
Private & Independent
Mailing Address
171 Oyster Point Blvd. 400
South San Francisco, CA 94080
Email Address
Surrozen Inc. is a biopharmaceutical company focused on harnessing the Wnt pathway for applications in regenerative medicine. Founded on breakthrough science from Stanford University and backed by The Column Group, Surrozen is implementing a surrogate Wnt platform with the potential to unlock stem cell control in a wide array of human tissues.
Surrozen LinkedIn Company Profile
Social Media
Surrozen Company Twitter Account
Company News
Surrozen News
Surrozen on Facebook
Surrozen on YouTube

Management Team

Email & Social
Timothy Kutzkey
  Timothy Kutzkey LinkedIn Profile  Timothy Kutzkey Twitter Account  Timothy Kutzkey News  Timothy Kutzkey on Facebook
Chief Executive Officer
Craig Parker
  Craig Parker LinkedIn Profile  Craig Parker Twitter Account  Craig Parker News  Craig Parker on Facebook
Chief Medical Officer
Trudy Vanhove
  Trudy Vanhove LinkedIn Profile  Trudy Vanhove Twitter Account  Trudy Vanhove News  Trudy Vanhove on Facebook
Chief Scientific Officer
Wen-Chen Yeh
  Wen-Chen Yeh LinkedIn Profile  Wen-Chen Yeh Twitter Account  Wen-Chen Yeh News  Wen-Chen Yeh on Facebook
Vice President
Yang Li
  Yang Li LinkedIn Profile  Yang Li Twitter Account  Yang Li News  Yang Li on Facebook
VP - Bus. Development
Reza Afkhami
  Reza Afkhami LinkedIn Profile  Reza Afkhami Twitter Account  Reza Afkhami News  Reza Afkhami on Facebook
VP - General Counsel
Sheela Peterson
  Sheela Peterson LinkedIn Profile  Sheela Peterson Twitter Account  Sheela Peterson News  Sheela Peterson on Facebook
VP - Human Resources
Christine McKinley
  Christine McKinley LinkedIn Profile  Christine McKinley Twitter Account  Christine McKinley News  Christine McKinley on Facebook



Browse more venture capital transactions:

Prev: 3/15/2019: ProdPerfect venture capital transaction
Next: 3/15/2019: Capital Markets Gateway venture capital transaction


Share this article


Where The Data Comes From

We report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary